Literature DB >> 9572175

Pretreatment of gastroschisis with transabdominal amniotic fluid exchange.

T Aktuğ1, N Demir, F M Akgür, M Olguner.   

Abstract

BACKGROUND: Intestinal thickening in gastroschisis results from prolonged exposure to amniotic fluid (AF). Experimental AF exchange has been shown to prevent intestinal thickening in gastroschisis. CASE: A 25-year-old primigravida was referred at 24 weeks' gestation with a prenatal diagnosis of gastroschisis. Transabdominal AF exchange was performed at 29 weeks. This pretreatment did not cause any complications and prevented intestinal thickening in our patient. Thus, we were able to perform primary fascial closure with an intra-abdominal pressure less than 5 mmHg. We began feeding the infant on the 5th day and discharged her on the 8th day.
CONCLUSION: Evidence obtained from this initial case seems promising for the further application of the AF exchange for prevention of intestinal thickening in gastroschisis.

Entities:  

Mesh:

Year:  1998        PMID: 9572175

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Amniotic fluid exchange vs amniofusion in gastroschisis.

Authors:  F M Akgür; M Olguner
Journal:  Surg Endosc       Date:  2003-10-28       Impact factor: 4.584

2.  Ferritin and bile acid levels during the intrauterine pre-treatment of gastroschisis by serial amnioexchange.

Authors:  Namık Demir; Mehmet Tunç Canda; Samil Kuday; Cengiz Oztürk; Orçun Sezer; Nihal Danaoğlu
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-03-01

3.  Is there a therapeutic role for fetoscopic surgery in the prenatal treatment of gastroschisis? A feasibility study in sheep.

Authors:  Thomas Kohl; Kristina Tchatcheva; Rüdiger Stressig; Ulrich Gembruch; Philip Kahl
Journal:  Surg Endosc       Date:  2009-03-05       Impact factor: 4.584

4.  Evaluation of diluted amniotic fluid effects on histological changes of intestine of rabbit fetus with gastroschisis.

Authors:  Mahmood Ashrafi; Mehrdad Hosseinpour; Mehdi Farid; Mohammad Hossein Sanei
Journal:  Pediatr Surg Int       Date:  2008-02-07       Impact factor: 1.827

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.